The first experience with sodium-glucose cotransporter 2 inhibitor for the treatment of systemic right ventricular failure.

MLA

Egorova, Anastasia D., et al. “The First Experience with Sodium-Glucose Cotransporter 2 Inhibitor for the Treatment of Systemic Right Ventricular Failure.” ESC Heart Failure, vol. 9, no. 3, June 2022, pp. 2007–12. EBSCOhost, https://doi.org/10.1002/ehf2.13871.

APA

Egorova, A. D., Nederend, M., Tops, L. F., Vliegen, H. W., Jongbloed, M. R. M., & Kiès, P. (2022). The first experience with sodium-glucose cotransporter 2 inhibitor for the treatment of systemic right ventricular failure. ESC Heart Failure, 9(3), 2007–2012. https://doi.org/10.1002/ehf2.13871

Chicago

Egorova, Anastasia D, Marieke Nederend, Laurens F Tops, Hubert W Vliegen, Monique R M Jongbloed, and Philippine Kiès. 2022. “The First Experience with Sodium-Glucose Cotransporter 2 Inhibitor for the Treatment of Systemic Right Ventricular Failure.” ESC Heart Failure 9 (3): 2007–12. doi:10.1002/ehf2.13871.